Let’s Talk Compliance: What the July 3rd Ruling on FTC Non-Compete Ban Means for the Health Care Industry

About this episode

The episode discusses the implications of the July 3rd ruling on the FTC's Non-compete Ban for the health care and life sciences industry.

In this episode, Benjamin Dryden, vice chair of Foley’s Antitrust & Competition Practice Group and David McMillan, managing principal of consulting and chief financial officer at PYA, discuss the recent July 3rd ruling on the U.S. Federal Trade Commission’s (FTC) Non-compete Ban and how this will affect the health care & life sciences industry.

People in this episode

Guest: David McMillan

Topics covered

• FTC Non-compete Ban
• health care industry
• antitrust
• competition

Keywords

• compliance
• health care law
• life sciences

More episodes of Health Care Law Today Podcast

• Let’s Talk Compliance: Not All wRVU’s are Created Equal (Part 1) · April 29, 2026 · 38 min
• Chanda Center for Health: Reimagining Access to and Delivery of Long-term Disability Care · January 5, 2026 · 44 min
• Let’s Talk Compliance: The Risks and Pitfalls of Health Care Supply Chain Compliance · July 16, 2025 · 43 min
• Let’s Talk Compliance: Physician Compensation Plans and Trends of 2024 · November 21, 2024 · 43 min
• Let’s Talk Compliance: Health Care Organizations Take Note: Trends and Pitfalls in the Bond Market Compliance Space · September 4, 2024 · 26 min
• Let’s Talk Compliance: What the FTC’s Ban on Non-Competes Means for the Health Care Industry · July 1, 2024 · 43 min